title: [Hormonal tocolysis in the second trimester of pregnancy for prevention delivery].
abstract: The objective of this preliminary announcement is to present the favourable results and the influence over the symptoms of premature delivery after peroral progesterone supplementation to the classical tocolytic therapy. The positive results of administering progesterone during the second trimester of pregnancy (24-35 gestation weeks) are outlined. The peroral progesterone should find its proper place in the complex therapy of premature delivery
authors.forename: B
authors.initials: B
authors.lastname: Marinov
authors.forename: K
authors.initials: K
authors.lastname: Milanova
authors.forename: B
authors.initials: B
authors.lastname: Manchev
authors.forename: D
authors.initials: D
authors.lastname: Aleksieva
mesh_terms: D000328:Adult; D036861:Delivery, Obstetric; D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000188:drug therapy / Q000517:prevention & control*; D011247:Pregnancy; D011262:Pregnancy Trimester, Second; D011374:Progesterone / Q000627:therapeutic use*; D011372:Progestins / Q000627:therapeutic use*; D015145:Tocolysis; D015149:Tocolytic Agents / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D011372:Progestins; D015149:Tocolytic Agents; D011374:Progesterone